Clinical trial
Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)
NCT04066660 is registered in ClinicalTrials.gov with Hi-Q Marine Biotech International, Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)
- Lead sponsor
- Hi-Q Marine Biotech International, Ltd.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 1, 2019
- Completion date
- July 31, 2024
- Enrollment
- 87 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced hepatocellular carcinoma